Cambria Cannabis ETF (TOKE)

12.10
Delayed Data
As of Jan 14
 -0.14 / -1.14%
Today’s Change
11.86
Today|||52-Week Range
28.78
-2.58%
Year-to-Date

Investment Objective

The investment seeks capital appreciation from investments in the global equity markets that have exposure to the broad cannabis industry. Under normal market conditions, at least 80% of the value of the fund's net assets (plus borrowings for investment purposes) will be invested in Cannabis Companies. The Advisor generally expects to invest in Cannabis Companies across a broad market capitalization spectrum of micro-, small-, and mid-capitalization stocks.

No recent news for Cambria Cannabis ETF.

Performance

1 month+0.16% 3 years--
3 months-12.58% 5 years--
1 year-32.46% Since inception-22.01%
Data through 01/15/2022

Quote Details

Previous close$12.24
Open day’s range12.10 – 12.24
Net asset value (NAV)12.23 (01/14/2022)
Daily volume12,869
Average volume (3 months)16,214
Data as of 4:00pm ET, 01/14/2022

Peer Comparisonvs. Miscellaneous sector ETFs

 TOKECategory
Performance 5-yr return--+13.67%
Expense Gross exp ratio0.59%--
Risk 5 year sharpe ratio----
Net assets$24.9M--
Average market cap$5.3B$14.9B
Average P/E18.125.4
Dividend / Share--0.08%

Competitors

No competitors data available.

Holdings

Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
IIPR Innovative Industrial Properties Inc12.98%
ARNA Arena Pharmaceuticals Inc8.65%
-- 8.32%
STZ Constellation Brands Inc8.12%
SMG Scotts Miracle-Gro Co6.20%
-- 4.80%
-- 4.74%
JAZZ Jazz Pharmaceuticals PLC4.50%
PM Philip Morris4.40%
TPB Turning Point Brands Inc4.26%